(LFVN) Lifevantage - Ratings and Ratios

LifeVantage Corporation (NASDAQ:LFVN) is a leading developer and marketer of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management products, and skin and hair care solutions. The companys product portfolio includes Protandim, a dietary supplement; LifeVantage Omega+, combining DHA and EPA Omega-3s, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio for gut health; LifeVantage IC Bright for eye and brain support; LifeVantage Daily Wellness for immune health; LifeVantage Rise AM & Reset PM System for nutrient support; LifeVantage D3+ for immune, bone, and cardiovascular health; PhysIQ Fat Burn and Prebiotic for weight management and gut health; Protandim for Dogs to combat oxidative stress in pets; and Axio, a nootropic energy drink mix. Under the TrueSciences brand, the company offers anti-aging skin care products, including collagen supplements, cleansers, creams, and sunscreens, as well as hair care products like shampoos, conditioners, and scalp treatments.

LifeVantage operates a direct sales model, distributing its products through a network of independent consultants and its e-commerce platform. The company has a significant international presence, with operations in over 20 countries, including the United States, Mexico, Japan, Australia, Hong Kong, the United Kingdom, Germany, and others. Headquartered in Lehi, Utah, LifeVantage focuses on innovation in the health and wellness industry, leveraging scientific research to develop products that address various aspects of human and animal health. Web URL:

Ticker Symbol: LFVN, Exchange: NASDAQ, Type: common stock, Country Origin: United States, GICS Sub Industry: Personal Care Products

Based on the provided and , here is a three-month forecast:

Over the next three months, LFVN is expected to experience increased volatility due to the rising ATR of 1.96, indicating heightened price fluctuations. The stock is currently trading below its SMA20 (19.02) and SMA50 (19.78), suggesting a bearish trend in the short term. However, the strong fundamental indicators, such as an RoE of 24.56 and a market cap of $209.48M, signal robust profitability and market confidence. The forward P/E of 0.00 indicates uncertainty in future earnings estimates, which could impact investor sentiment. Overall, LFVN may face short-term price corrections but is well-positioned for long-term growth driven by its diversified product portfolio and global distribution network.